Somnomed Ltd has released a press release.
Chairmans Letter
Filed with ASX ·
On 6ix: 6ix.com/news/chairmans-letter-2
6ix hasn’t read this filing yet.
In the deck
Earlier from Somnomed
- Continuing High Growth in the Third Quarter
- SomnoMed continues to break records in 4th Quarter
- SomnoMed Accelerates Growth beyond Forecasts
- SomnoMed reports solid growth and stronger profits
- SomnoMed posts new record in Q3
Later from Somnomed
- Results of Institutional Entitlement Offer
- Derek Smith appointed Global CEO of SomnoMed
- Strong finish to the financial year for SomnoMed
- FDA 510k approval for SomnoDent Alpha
- Sales growth accelerating
Follow Somnomed into a list and get an email when it puts out news.
Follow Somnomed